These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
Ontario, Canada
|
|
98-1220792
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(IRS Employer Identification No.)
|
|
|
|
|
|
895 Don Mills Road, Bldg. 2, Suite 900
|
|
|
|
Toronto, Ontario, Canada, M3C 1W3
|
|
|
|
(Address of principal executive offices)
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
Item 1.
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
Item 2.
|
|
|
||
|
|
|
|
|
|
|
Item 3.
|
|
|
||
|
|
|
|
|
|
|
Item 4.
|
|
|
||
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
Item 1.
|
|
|
||
|
|
|
|
|
|
|
Item 1A.
|
|
|
||
|
|
|
|
|
|
|
Item 2.
|
|
|
||
|
|
|
|
|
|
|
Item 3.
|
|
|
||
|
|
|
|
|
|
|
Item 4.
|
|
|
||
|
|
|
|
|
|
|
Item 5.
|
|
|
||
|
|
|
|
|
|
|
Item 6.
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
Three Months
Ended March 31, |
||||||
|
|
|
2019
|
|
2018
|
||||
|
|
|
|
|
|
||||
|
|
|
(Unaudited)
|
||||||
|
Revenue
|
|
$
|
2,130
|
|
|
$
|
2,373
|
|
|
Cost of revenue
|
|
1,435
|
|
|
1,930
|
|
||
|
Gross profit
|
|
695
|
|
|
443
|
|
||
|
Operating expenses:
|
|
|
|
|
||||
|
Sales and marketing
|
|
453
|
|
|
781
|
|
||
|
Research and development
|
|
697
|
|
|
1,111
|
|
||
|
General and administrative
|
|
1,252
|
|
|
3,000
|
|
||
|
|
|
2,402
|
|
|
4,892
|
|
||
|
Loss from operations
|
|
(1,707
|
)
|
|
(4,449
|
)
|
||
|
Other income (expense):
|
|
|
|
|
||||
|
Interest expense, related party
|
|
(142
|
)
|
|
(558
|
)
|
||
|
Interest expense
|
|
(3
|
)
|
|
—
|
|
||
|
Other income (expense), net
|
|
8
|
|
|
(126
|
)
|
||
|
Net loss from continuing operations
|
|
(1,844
|
)
|
|
(5,133
|
)
|
||
|
Net loss from discontinued operations
|
|
—
|
|
|
(1,690
|
)
|
||
|
Net loss
|
|
$
|
(1,844
|
)
|
|
$
|
(6,823
|
)
|
|
Net loss per share:
|
|
|
|
|
||||
|
Continuing operations
|
|
$
|
(0.82
|
)
|
|
$
|
(5.35
|
)
|
|
Discontinued operations
|
|
—
|
|
|
(1.76
|
)
|
||
|
Net loss per share basic and diluted
|
|
$
|
(0.82
|
)
|
|
$
|
(7.11
|
)
|
|
Shares used in computing net loss per share:
|
|
|
|
|
||||
|
Basic and diluted
|
|
2,236,590
|
|
|
959,828
|
|
||
|
|
|
Three Months
Ended March 31, |
||||||
|
|
|
2019
|
|
2018
|
||||
|
|
|
|
|
|
||||
|
|
|
(Unaudited)
|
||||||
|
Net loss
|
|
$
|
(1,844
|
)
|
|
$
|
(6,823
|
)
|
|
Other comprehensive income:
|
|
|
|
|
||||
|
Foreign currency translation adjustment
|
|
40
|
|
|
641
|
|
||
|
Total other comprehensive income
|
|
40
|
|
|
641
|
|
||
|
Comprehensive loss
|
|
$
|
(1,804
|
)
|
|
$
|
(6,182
|
)
|
|
|
March 31,
2019 |
|
December 31,
2018 |
||||
|
|
|
|
|
||||
|
Assets
|
(Unaudited)
|
||||||
|
Current assets:
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
139
|
|
|
$
|
341
|
|
|
Accounts receivable, net
|
859
|
|
|
1,142
|
|
||
|
Inventories
|
1,247
|
|
|
1,230
|
|
||
|
Other current assets
|
596
|
|
|
784
|
|
||
|
Total current assets
|
2,841
|
|
|
3,497
|
|
||
|
Investment in affiliate
|
2,100
|
|
|
2,100
|
|
||
|
Property and equipment, net
|
5
|
|
|
6
|
|
||
|
Intangible assets, net
|
3,101
|
|
|
3,348
|
|
||
|
Goodwill
|
1,385
|
|
|
1,385
|
|
||
|
Other assets
|
1,114
|
|
|
950
|
|
||
|
Total assets
|
$
|
10,546
|
|
|
$
|
11,286
|
|
|
Liabilities and Shareholders’ Deficit
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
5,298
|
|
|
$
|
4,600
|
|
|
Accrued liabilities
|
1,165
|
|
|
1,711
|
|
||
|
Accrued payroll and employee compensation
|
1,470
|
|
|
1,717
|
|
||
|
Deferred revenue
|
692
|
|
|
988
|
|
||
|
Debt, related party
|
500
|
|
|
500
|
|
||
|
Line of credit
|
365
|
|
|
100
|
|
||
|
Other current liabilities
|
104
|
|
|
23
|
|
||
|
Total current liabilities
|
9,594
|
|
|
9,639
|
|
||
|
Series A redeemable preferred shares
|
6,701
|
|
|
6,571
|
|
||
|
Deferred revenue, long-term
|
772
|
|
|
667
|
|
||
|
Long-term debt, related party
|
523
|
|
|
—
|
|
||
|
Other non-current liabilities
|
138
|
|
|
16
|
|
||
|
Total liabilities
|
17,728
|
|
|
16,893
|
|
||
|
Commitments and contingencies (Note 14)
|
|
|
|
|
|
||
|
Shareholders’ deficit:
|
|
|
|
||||
|
Common shares, no par value; 2,300,071 and 2,219,141 shares issued and outstanding as of March 31, 2019 and December 31, 2018, respectively
|
183,753
|
|
|
183,524
|
|
||
|
Accumulated other comprehensive loss
|
(1,776
|
)
|
|
(1,816
|
)
|
||
|
Accumulated deficit
|
(189,159
|
)
|
|
(187,315
|
)
|
||
|
Total shareholders’ deficit
|
(7,182
|
)
|
|
(5,607
|
)
|
||
|
Total liabilities and shareholders’ deficit
|
$
|
10,546
|
|
|
$
|
11,286
|
|
|
|
Three Months
Ended March 31, |
||||||
|
|
2019
|
|
2018
|
||||
|
|
|
|
|
||||
|
Operating activities:
|
(Unaudited)
|
||||||
|
Net loss
|
$
|
(1,844
|
)
|
|
$
|
(6,823
|
)
|
|
Adjustments to reconcile net loss to cash used in operating activities:
|
|
|
|
||||
|
Depreciation and amortization
|
267
|
|
|
1,484
|
|
||
|
Share-based compensation
|
124
|
|
|
821
|
|
||
|
Preferred shares interest expense, related party
|
130
|
|
|
—
|
|
||
|
Amortization of debt issuance costs
|
—
|
|
|
183
|
|
||
|
Fair value adjustment of warrants
|
—
|
|
|
(259
|
)
|
||
|
Payment in-kind interest expense, related party
|
—
|
|
|
63
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
||||
|
Accounts receivable
|
282
|
|
|
1,036
|
|
||
|
Inventories
|
(16
|
)
|
|
709
|
|
||
|
Accounts payable and accrued liabilities
|
70
|
|
|
2,228
|
|
||
|
Accrued payroll and employee compensation
|
(62
|
)
|
|
(823
|
)
|
||
|
Deferred revenue
|
(191
|
)
|
|
(465
|
)
|
||
|
Other assets and liabilities, net
|
250
|
|
|
(265
|
)
|
||
|
Net cash used in operating activities
|
(990
|
)
|
|
(2,111
|
)
|
||
|
Investing activities:
|
|
|
|
||||
|
Purchase of property and equipment
|
—
|
|
|
(8
|
)
|
||
|
Net cash used in investing activities
|
—
|
|
|
(8
|
)
|
||
|
Financing activities:
|
|
|
|
||||
|
Proceeds from debt - related party
|
523
|
|
|
—
|
|
||
|
Proceeds from line of credit, net
|
265
|
|
|
—
|
|
||
|
Payments on debt, related party
|
—
|
|
|
(192
|
)
|
||
|
Net cash provided by (used in) financing activities
|
788
|
|
|
(192
|
)
|
||
|
Effect of exchange rate changes on cash
|
—
|
|
|
40
|
|
||
|
Net decrease in cash and cash equivalents
|
(202
|
)
|
|
(2,271
|
)
|
||
|
Cash and cash equivalents, beginning of period
|
341
|
|
|
4,598
|
|
||
|
Cash and cash equivalents, end of period
|
139
|
|
|
2,327
|
|
||
|
Less: Cash and cash equivalents, discontinued operations
|
—
|
|
|
2,163
|
|
||
|
Cash and cash equivalents of continuing operations, end of period
|
$
|
139
|
|
|
$
|
164
|
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
||||
|
Cash paid for interest
|
$
|
10
|
|
|
$
|
379
|
|
|
Supplemental disclosures of non-cash investing and financing activities:
|
|
|
|
||||
|
Issuance of common shares for settlement of related party liabilities
|
$
|
105
|
|
|
$
|
483
|
|
|
Issuance of common shares for settlement of liabilities
|
$
|
—
|
|
|
$
|
787
|
|
|
|
Common Shares
|
|
Accumulated
Other Comprehensive Loss |
|
Accumulated
Deficit |
|
Total
Shareholders' Deficit |
|||||||||||
|
|
Shares
|
|
Amount
|
|
||||||||||||||
|
Balance at January 1, 2019
|
2,219,141
|
|
|
$
|
183,524
|
|
|
$
|
(1,816
|
)
|
|
$
|
(187,315
|
)
|
|
$
|
(5,607
|
)
|
|
Issuance of common shares pursuant to the vesting of
restricted stock units |
38,930
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Issuance of restricted stock awards
|
42,000
|
|
|
105
|
|
|
—
|
|
|
—
|
|
|
105
|
|
||||
|
Share-based compensation
|
—
|
|
|
124
|
|
|
—
|
|
|
—
|
|
|
124
|
|
||||
|
Other comprehensive income
|
—
|
|
|
—
|
|
|
40
|
|
|
—
|
|
|
40
|
|
||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,844
|
)
|
|
(1,844
|
)
|
||||
|
Balance at March 31, 2019
|
2,300,071
|
|
|
$
|
183,753
|
|
|
$
|
(1,776
|
)
|
|
$
|
(189,159
|
)
|
|
$
|
(7,182
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
|
|
Common Shares
|
|
Accumulated
Other Comprehensive Loss |
|
Accumulated
Deficit |
|
Total
Shareholders' Equity |
|||||||||||
|
|
Shares
|
|
Amount
|
|
||||||||||||||
|
Balance at January 1, 2018
|
889,461
|
|
|
$
|
173,871
|
|
|
$
|
(1,981
|
)
|
|
$
|
(161,427
|
)
|
|
$
|
10,463
|
|
|
Adoption of accounting standards
|
—
|
|
|
—
|
|
|
—
|
|
|
320
|
|
|
320
|
|
||||
|
Issuance of common shares for warrant exchange
|
178,875
|
|
|
1,364
|
|
|
—
|
|
|
—
|
|
|
1,364
|
|
||||
|
Issuance of common shares for settlement of related party
interest expense
|
43,120
|
|
|
483
|
|
|
—
|
|
|
—
|
|
|
483
|
|
||||
|
Issuance of common shares pursuant to the vesting of
restricted stock units
|
26,353
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Issuance of restricted stock awards
|
40,654
|
|
|
787
|
|
|
—
|
|
|
—
|
|
|
787
|
|
||||
|
Share-based compensation
|
—
|
|
|
821
|
|
|
—
|
|
|
—
|
|
|
821
|
|
||||
|
Other comprehensive income
|
—
|
|
|
—
|
|
|
641
|
|
|
—
|
|
|
641
|
|
||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
(6,823
|
)
|
|
(6,823
|
)
|
||||
|
Balance at March 31, 2018
|
1,178,463
|
|
|
$
|
177,326
|
|
|
$
|
(1,340
|
)
|
|
$
|
(167,930
|
)
|
|
$
|
8,056
|
|
|
1.
|
Organization and Business
|
|
2.
|
Significant Accounting Policies
|
|
3.
|
Discontinued Operations
|
|
|
|
Three Months Ended
March 31, 2018
|
||
|
Revenue
|
|
$
|
17,075
|
|
|
Cost of revenue
|
|
11,507
|
|
|
|
Gross profit
|
|
5,568
|
|
|
|
Sales and marketing
|
|
3,609
|
|
|
|
Research and development
|
|
177
|
|
|
|
General and administrative
|
|
2,422
|
|
|
|
|
|
6,208
|
|
|
|
Loss from operations of discontinued operations
|
|
(640
|
)
|
|
|
Other expense of discontinued operations:
|
|
|
||
|
Interest expense, related party
|
|
(97
|
)
|
|
|
Interest expense
|
|
(453
|
)
|
|
|
Other expense, net
|
|
(160
|
)
|
|
|
Loss before income taxes of discontinued operations
|
|
(1,350
|
)
|
|
|
Provision for income taxes of discontinued operations
|
|
340
|
|
|
|
Net loss of discontinued operations
|
|
$
|
(1,690
|
)
|
|
|
|
Three Months Ended
March 31, 2018
|
||
|
Depreciation and amortization
|
|
$
|
638
|
|
|
Capital expenditures
|
|
$
|
8
|
|
|
4.
|
Certain Balance Sheet Items
|
|
|
March 31,
2019 |
|
December 31,
2018
|
||||
|
Raw materials
|
$
|
240
|
|
|
$
|
255
|
|
|
Work in process
|
302
|
|
|
282
|
|
||
|
Finished goods
|
705
|
|
|
693
|
|
||
|
|
$
|
1,247
|
|
|
$
|
1,230
|
|
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
Deferred cost - service contracts
|
$
|
329
|
|
|
$
|
385
|
|
|
Prepaid insurance and services
|
252
|
|
|
344
|
|
||
|
Other
|
15
|
|
|
55
|
|
||
|
|
$
|
596
|
|
|
$
|
784
|
|
|
|
March 31, 2019
|
|
December 31, 2018
|
||||
|
Prepaid insurance and services
|
$
|
619
|
|
|
$
|
653
|
|
|
Deferred cost – service contracts
|
241
|
|
|
270
|
|
||
|
Right-of-use asset
|
225
|
|
|
—
|
|
||
|
Other
|
29
|
|
|
27
|
|
||
|
|
$
|
1,114
|
|
|
$
|
950
|
|
|
5.
|
Intangible Assets
|
|
|
March 31,
2019 |
|
December 31,
2018
|
||||
|
Developed technology
|
$
|
13,383
|
|
|
$
|
13,383
|
|
|
Channel partner relationships
|
730
|
|
|
730
|
|
||
|
Capitalized development costs
(1)
|
2,959
|
|
|
2,918
|
|
||
|
Customer relationships
|
380
|
|
|
380
|
|
||
|
|
17,452
|
|
|
17,411
|
|
||
|
Accumulated amortization:
|
|
|
|
||||
|
Developed technology
|
(12,348
|
)
|
|
(12,222
|
)
|
||
|
Channel partner relationships
|
(267
|
)
|
|
(233
|
)
|
||
|
Capitalized development costs
(1)
|
(1,768
|
)
|
|
(1,655
|
)
|
||
|
Customer relationships
|
(318
|
)
|
|
(303
|
)
|
||
|
|
(14,701
|
)
|
|
(14,413
|
)
|
||
|
Total finite-lived assets, net
|
2,751
|
|
|
2,998
|
|
||
|
Indefinite-lived intangible assets - trade names
|
350
|
|
|
350
|
|
||
|
Total intangible assets, net
|
$
|
3,101
|
|
|
$
|
3,348
|
|
|
(1)
|
Includes the impact of foreign currency exchange rate fluctuations.
|
|
6.
|
Investment in Affiliate
|
|
7.
|
Debt
|
|
8.
|
Preferred Shares
|
|
9.
|
Fair Value Measurements
|
|
10.
|
Share Capital
|
|
Date issued
|
|
Contractual life (years)
|
|
Exercise price
|
|
Number outstanding
|
|
Expiration
|
|
|
May 2015
|
|
5
|
|
$800.00
|
|
4,200
|
|
|
May 31, 2020
|
|
October 2015
|
|
5
|
|
$466.00
|
|
2,010
|
|
|
October 14, 2020
|
|
December 2015
|
|
5
|
|
$500.00
|
|
5,138
|
|
|
December 15, 2020
|
|
December 2015
|
|
5
|
|
$216.00
|
|
7,500
|
|
(1)
|
December 4, 2020
|
|
March 2016
|
|
5
|
|
$500.00
|
|
150
|
|
|
March 4, 2021
|
|
November 2016
|
|
3
|
|
$400.00
|
|
125
|
|
|
November 8, 2019
|
|
August 2017
|
|
5
|
|
$42.00
|
|
37,500
|
|
|
August 11, 2022
|
|
August 2017
|
|
5
|
|
$42.00
|
|
11,876
|
|
|
August 16, 2022
|
|
August 2017
|
|
5
|
|
$42.00
|
|
25,625
|
|
|
August 22, 2022
|
|
April 2018
|
|
5
|
|
$5.60
|
|
111,563
|
|
|
April 17, 2023
|
|
|
|
|
|
|
|
205,687
|
|
(2)
|
|
|
(1)
|
If the Company or any subsidiary thereof, at any time while this warrant is outstanding, enters into a Variable Rate Transaction (“VRT”) (as defined in the purchase agreement) and the issue price, conversion price or exercise price per share applicable thereto is less than the warrant exercise price then in effect, the exercise price shall be reduced to equal the VRT price.
|
|
(2)
|
Includes warrants to purchase up to
40,000
common shares, in the aggregate, outstanding to related parties at
March 31, 2019
.
|
|
11.
|
Equity Incentive Plans
|
|
|
|
Three Months
Ended March 31, |
||||||
|
|
|
2019
|
|
2018
|
||||
|
Cost of sales
|
|
$
|
693
|
|
|
$
|
32,083
|
|
|
Sales and marketing
|
|
10,313
|
|
|
183,775
|
|
||
|
Research and development
|
|
18,471
|
|
|
96,300
|
|
||
|
General and administrative
|
|
94,565
|
|
|
508,626
|
|
||
|
Total share-based compensation expense
|
|
$
|
124,042
|
|
|
$
|
820,784
|
|
|
12.
|
Net Loss per Share
|
|
|
Three Months
Ended March 31, |
||||
|
|
2019
|
|
2018
|
||
|
Common share purchase warrants
|
205,687
|
|
|
110,275
|
|
|
Restricted stock not yet vested or released
|
114,066
|
|
|
106,026
|
|
|
Options outstanding
|
10,298
|
|
|
22,019
|
|
|
Convertible notes
|
—
|
|
|
40,833
|
|
|
Convertible notes interest
|
—
|
|
|
40,945
|
|
|
13.
|
Related Party Transactions
|
|
14.
|
Commitments and Contingencies
|
|
|
Product
Warranty |
|
Deferred
Revenue |
||||
|
Liability at January 1, 2019
|
$
|
22
|
|
|
$
|
1,655
|
|
|
Settlements made during the period
|
—
|
|
|
(355
|
)
|
||
|
Change in liability for warranties issued during the period
|
—
|
|
|
164
|
|
||
|
Change in liability for pre-existing warranties
|
(22
|
)
|
|
—
|
|
||
|
Liability at March 31, 2019
|
$
|
—
|
|
|
$
|
1,464
|
|
|
Current liability
|
$
|
—
|
|
|
$
|
692
|
|
|
Non-current liability
|
—
|
|
|
772
|
|
||
|
Liability at March 31, 2019
|
$
|
—
|
|
|
$
|
1,464
|
|
|
15.
|
Subsequent Event
|
|
•
|
In May 2019, the Company signed purchase agreements for a private placement of 340,000 common shares of the Company for a purchase price of $680,000, or $2.00 per common share. The transaction is anticipated to close on or about May 15, 2019 subject to customary closing conditions. The Company intends to use the proceeds from the offering for general corporate and working capital purposes.
|
|
|
|
Three Months
Ended March 31, |
||||
|
|
|
2019
|
|
2018
|
||
|
Revenue
|
|
100.0
|
%
|
|
100.0
|
%
|
|
Cost of revenue
|
|
67.4
|
|
|
81.3
|
|
|
Gross profit
|
|
32.6
|
|
|
18.7
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
Sales and marketing
|
|
21.3
|
|
|
32.9
|
|
|
Research and development
|
|
32.7
|
|
|
46.8
|
|
|
General and administrative
|
|
58.8
|
|
|
126.4
|
|
|
|
|
112.8
|
|
|
206.1
|
|
|
Loss from operations
|
|
(80.2
|
)
|
|
(187.4
|
)
|
|
Interest expense
|
|
(6.8
|
)
|
|
(23.5
|
)
|
|
Other income (expense), net
|
|
0.4
|
|
|
(5.3
|
)
|
|
Net loss from continuing operations
|
|
(86.6
|
)
|
|
(216.2
|
)
|
|
Net loss from discontinued operations
|
|
—
|
|
|
(71.2
|
)
|
|
Net loss
|
|
(86.6
|
)%
|
|
(287.4
|
)%
|
|
|
|
Three Months
Ended March 31, |
|
|
|||||
|
|
|
2019
|
|
2018
|
|
Change
|
|||
|
Gross profit
|
|
695
|
|
|
443
|
|
|
56.9
|
%
|
|
Gross margin
|
|
32.6
|
%
|
|
18.7
|
%
|
|
13.9
|
pt
|
|
|
|
Maturity Date
|
|
Interest Rate
|
|
Amount Outstanding
|
||
|
Series A redeemable preferred shares
|
|
11/13/2020
|
|
8.0%
|
|
$
|
6,701
|
|
|
Unsecured debt - related party
|
|
1/10/2021
|
|
8.0%
|
|
$
|
523
|
|
|
Secured debt - related party
|
|
6/13/2019
|
|
2.0%
|
|
$
|
500
|
|
|
Line of credit
|
|
12/19/2019
|
|
6.0%
|
|
$
|
365
|
|
|
|
|
Three Months
Ended March 31, |
||||||
|
|
|
2019
|
|
2018
|
||||
|
Net cash used in operating activities
|
|
$
|
(990
|
)
|
|
$
|
(2,111
|
)
|
|
Net cash used in investing activities
|
|
$
|
—
|
|
|
$
|
(8
|
)
|
|
Net cash provided by (used in) financing activities
|
|
$
|
788
|
|
|
$
|
(192
|
)
|
|
Item 1.
|
Legal Proceedings.
|
|
Exhibit
|
|
Filed
|
Incorporated by Reference
|
||
|
Number
|
Description
|
Herewith
|
Form
|
File No.
|
Date Filed
|
|
|
|
|
|
|
|
|
3.1
|
|
6-K
|
001-36532
|
3/25/2015
|
|
|
|
|
|
|
|
|
|
3.2
|
|
6-K
|
001-36532
|
7/17/2017
|
|
|
|
|
|
|
|
|
|
3.3
|
|
8-K
|
001-36532
|
10/2/2018
|
|
|
|
|
|
|
|
|
|
3.4
|
|
8-K
|
001-36532
|
10/5/2018
|
|
|
|
|
|
|
|
|
|
3.5
|
|
8-K
|
001-36532
|
11/5/2018
|
|
|
|
|
|
|
|
|
|
3.6
|
|
8-K
|
001-36532
|
11/14/2018
|
|
|
|
|
|
|
|
|
|
3.7
|
|
6-K
|
001-36532
|
7/17/2017
|
|
|
|
|
|
|
|
|
|
3.8
|
|
6-K
|
001-36532
|
5/12/2017
|
|
|
|
|
|
|
|
|
|
10.1
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.2
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.3
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
10.4
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
31.1
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
31.2
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
32
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
101.INS
|
XBRL Instance Document
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase
|
X
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE
|
XBRL Taxonomy Presentation Linkbase
|
X
|
|
|
|
|
|
|
|
Sphere 3D Corp.
|
|
|
|
|
|
|
|
|
Date:
|
May 15, 2019
|
|
By:
|
/s/ Peter Tassiopoulos
|
|
|
|
|
|
Peter Tassiopoulos
Chief Executive Officer
(Principal Executive Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|